Academic literature on the topic 'Fragile X syndrome'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Fragile X syndrome.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Fragile X syndrome"
Tassanakijpanich, Nattaporn, Ana María Cabal-Herrera, Maria Jimena Salcedo-Arellano, and Randi Jenssen Hagerman. "Fragile X Syndrome and Targeted Treatments." Journal of Biomedicine and Translational Research 6, no. 1 (March 31, 2020): 23–33. http://dx.doi.org/10.14710/jbtr.v6i1.7321.
Full textPhalen, J. A. "Fragile X Syndrome." Pediatrics in Review 26, no. 5 (May 1, 2005): 181–82. http://dx.doi.org/10.1542/pir.26-5-181.
Full textHagerman, Paul J., and Randi Hagerman. "Fragile X syndrome." Current Biology 31, no. 6 (March 2021): R273—R275. http://dx.doi.org/10.1016/j.cub.2021.01.043.
Full textMillichap, J. Gordon. "Fragile-X Syndrome." Pediatric Neurology Briefs 2, no. 3 (March 1, 1988): 18. http://dx.doi.org/10.15844/pedneurbriefs-2-3-3.
Full textMcLennan, Yingratana, Jonathan Polussa, Flora Tassone, and Randi Hagerman. "Fragile X Syndrome." Current Genomics 12, no. 3 (May 1, 2011): 216–24. http://dx.doi.org/10.2174/138920211795677886.
Full textPhalen, James A. "Fragile X Syndrome." Pediatrics In Review 26, no. 5 (May 1, 2005): 181–82. http://dx.doi.org/10.1542/pir.26.5.181.
Full textDubey, Sneha R., and Hanokh J. Chakranarayan. "Fragile X Syndrome." International Journal of Advances in Nursing Management 6, no. 4 (2018): 339. http://dx.doi.org/10.5958/2454-2652.2018.00078.1.
Full textMcNally, Steve. "Fragile X syndrome." Learning Disability Practice 13, no. 10 (December 8, 2010): 11. http://dx.doi.org/10.7748/ldp.13.10.11.s19.
Full textAtkinson, Stacey. "Fragile X syndrome." Learning Disability Practice 18, no. 3 (March 30, 2015): 15. http://dx.doi.org/10.7748/ldp.18.3.15.s18.
Full textSinéad, Foran. "Fragile X syndrome." Learning Disability Practice 21, no. 4 (July 24, 2018): 17. http://dx.doi.org/10.7748/ldp.21.4.17.s17.
Full textDissertations / Theses on the topic "Fragile X syndrome"
Yu, Sui. "Molecular basis of fragile X syndrome /." Title page, contents and summary only, 1992. http://web4.library.adelaide.edu.au/theses/09PH/09phy937.pdf.
Full textBakker-van, Kempen Katharina Elisabeth. "Mouse models for the fragile X syndrome." [S.l.] : Rotterdam : [The Author] ; Erasmus University [Host], 2002. http://hdl.handle.net/1765/12094.
Full textWang, Qin. "Molecular genetic analysis of fragile X syndrome." Thesis, King's College London (University of London), 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.284140.
Full textHussein, Sultana Muhammad School of Pathology UNSW. "Fragile X mental retardation and fragile X chromosomes in the Indonesian population." Awarded by:University of New South Wales. School of Pathology, 1998. http://handle.unsw.edu.au/1959.4/33198.
Full textMankowski, Jean Boswell Simeonsson Rune J. Hatton Deborah Dominey. "Mood, anxiety, and stress in mothers of children with Fragile X syndrome, autism, and Fragile X syndrome and autism." Chapel Hill, N.C. : University of North Carolina at Chapel Hill, 2007. http://dc.lib.unc.edu/u?/etd,772.
Full textTitle from electronic title page (viewed Dec. 18, 2007). "... in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Education (School Psychology)." Discipline: Education; Department/School: Education.
Kogan, Cary Samuel. "Visual processing deficits in the Fragile X Syndrome." Thesis, McGill University, 2005. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=85927.
Full textIn the first set of experiments, immunohistological studies of unaffected human and primate brain tissue were carried out to reveal the staining pattern for Fragile X Mental Retardation Protein (FMRP), the protein product of the FMR1 gene, within the two main subcortical pathways at the level of the lateral geniculate nucleus (LGN). FMRP is expressed in significantly greater quantity within the magnocellular (M) neurons of the LGN when compared to levels obtained from the parvocellular (P) neurons. This finding suggests that M neurons depend on FMRP to greater extent than P neurons for determining their normal structure and function. A subsequent histological analysis of the LGN from a FXS affected individual revealed atypical LGN composed of small-sized neurons that were more P- than M-like. This result supports the notion that with the lack of FMR1 expression as occurs in FXS, the impact is greatest to M neuron morphology.
A second set of experiments explored the idea that the M neuron pathology in FXS results in a functional deficit for processing of visual information carried by this pathway. Detection thresholds for stimuli known to probe either M or P-pathway integrity were obtained from individuals affected by FXS as well as age- and developmental-matched control participants. In support of this hypothesis, FXS affected individuals displayed significantly elevated thresholds for M-but not P-specific achromatic visual stimuli. The selectivity of this deficit was verified in a consequent experiment that evaluated colour vision, a visual attribute known to be exclusively processed by the P-pathway. Affected individuals did not differ significantly from developmental-matched control participants in their ability to detect chromatic stimuli. Finally, the effect of the M pathway deficit on cortical visual function was assessed. Results of these experiments reveal that the thresholds for detection of coherent motion, but not form, are significantly elevated in the FXS group. This finding suggests that the parietal (dorsal) visual stream, the major cortical recipient of input from the M pathway, is detrimentally affected in FXS.
A third experiment examines the extent to which the M pathway deficit impacts on cortical visual functioning by employing stimuli of varying complexity that probe the parietal (dorsal) and temporal (ventral) visual streams separately. Results suggest that FXS affected individuals have a pervasive deficit in their ability to detect both simple and more complex forms of motion. In contrast, these same individuals have normal detection thresholds for simple form stimuli. However, with more complex form stimuli affected individuals have significant elevations in threshold. Taken together these results support the notion that the M pathway deficit is amplified at higher levels of visual processing and further, that FXS affected individuals have difficulties integrating all early visual information.
Sabaratnam, Mangayatkarasy. "The fragile-X syndrome in a selected population." Thesis, Queen Mary, University of London, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.309234.
Full textSiomi, Mikiko. "Characterization of the fragile X syndrome gene products." Kyoto University, 1994. http://hdl.handle.net/2433/160849.
Full textKyoto University (京都大学)
0048
新制・論文博士
博士(農学)
乙第8739号
論農博第1951号
新制||農||691(附属図書館)
学位論文||H6||N2760(農学部図書室)
UT51-94-Z490
(主査)教授 小田 順一, 教授 左右 田健次, 教授 駒野 徹
学位規則第4条第2項該当
Aloisi, Elisabetta. "Involvement of mGluR5/Homer crosstalk disruption in the pathophysiology of Fragile X Syndrome." Thesis, Bordeaux, 2015. http://www.theses.fr/2015BORD0006/document.
Full textFragile X Syndrome (FXS) is the most common inherited form of intellectualdisability and autism. FXS is caused by a mutation in the fragile X mental retardation 1(Fmr1) gene which leads to the lack of the encoded FMRP protein. FMRP is an RNAbinding protein involved in protein synthesis regulation at synapses. Many evidencessuggest a central role of the Group-I metabotropic glutamate receptor subtype 5(mGluR5) in the FXS pathophysiology. In particular, an exaggerated signaling responsefollowing mGluR5 activation may underlie synaptic dysfunction in this disorder.Although much work has focused on the dysregulation of synaptic protein synthesis as aconsequence of this enhanced mGluR5 signaling, it becomes clear that in FXS there isalso an altered balance of mGluR5 association with Homer scaffolding proteins, whichare postsynaptic density (PSD) partners of mGluR5. Although an extensive literaturedescribes the mGluR5/Homer association, very little is known about the consequences ofthe disruption of this interaction in the FXS context. Therefore, the goal of my thesis wasto study the consequences of mGluR5/Homer crosstalk disruption in the Fmr1 knockout(KO) mouse model of FXS in terms of properties and functions of mGluR5, such asexpression during development, surface expression and axonal/dendritic targeting,agonist-induced internalization, surface dynamics and mGluR5-mediated modulation ofNMDA receptor (NMDAR) currents.In a first set of experiments we investigated the mGluR5 surface expression incultured hippocampal neurons from WT and Fmr1 KO mice by usingimmunofluorescence techniques and biotinylation assay. We found that mGluR5 wasmore expressed on the neuronal surface and was differently distributed in dendrites andaxons of Fmr1 KO cultured neurons. We then hypothesized that these alterations were adirect consequence of the mGluR5/Homer crosstalk disruption. We demonstrated thatthe altered expression and targeting of mGluR5 were critically dependent onmGluR5/Homer crosstalk disruption. We also observed that mGluR5 did not undergointernalization upon sustained mGluR5 activation with DHPG in Fmr1 KO neurons.This latter phenotype, however, was not dependent on the disruption of themGluR5/Homer crosstalk. Altogether, these results demonstrate that mGluR5/Homercrosstalk disruption contributes to the pathophysiology of FXS altering expression andtargeting of mGluR5 on the surface of Fmr1 KO neurons.In the second part of my study we investigated the consequences of the disruptedmGluR5/Homer crosstalk for the mGluR5 surface dynamics, and consequently forNMDAR function in Fmr1 KO neurons. Using a combination of live-cell imaging andsingle-molecule tracking, we found that mGluR5/Homer crosstalk disruption specificallyincreased the mGluR5 lateral diffusion at the synapse of cultured Fmr1 KO hippocampalneurons. The higher mGluR5 mobility resulted in an increased probability of transientphysical interaction with NMDAR in the PSD of Fmr1 KO. This interaction altered themGluR5-mediated modulation of NMDAR currents as evidenced by the two followingchanges. First, using patch-clamp recordings from CA1 pyramidal neurons, we foundthat NMDAR-mediated excitatory postsynaptic currents (NMDAR-EPSCs) evoked bySchaffer collateral stimulation showed lower amplitudes in Fmr1 KO neurons. Second,the postsynaptic expression of mGluR5 mediated long term depression (LTD) ofNMDAR-EPSCs was reduced in Fmr1 KO neurons. Finally, we demonstrated that thesedefects in NMDA currents were strongly dependent on the mGluR5/Homer crosstalkdisruption and altered mGluR5 dynamics.Altogether, our results show that mGluR5/Homer disruption contributes to themGluR5 dysregulation in Fmr1 KO neurons. This study might have implication for thetreatment of mGluR5 synaptic dysfunctions in FXS by targeting mGluR5/Homerinteraction and provide new suggestions to correct the defective signaling underlyingcognitive impairment and autism
Haberl, Matthias. "Studying Neuronal Connectivity in the Mouse Brain in Normal Condition and Fragile X Syndrome." Thesis, Bordeaux, 2014. http://www.theses.fr/2014BORD0480/document.
Full textThe goal of this work was the investigation of the anatomical and functionalconnectivity of neuronal networks and the development of novel tools for thispurpose. Since the latter aspect is a major focus of current neuroscience, we firstsought a novel viral tracer enabling sparse neuronal reconstruction and neuronclassification. We then applied this and other techniques to probe neuronalconnectivity defects in Fragile X Syndrome.In the first part we discussed the merits and drawbacks of a emergingtechnique using a new type of viral vector that allows in a unique manner mapping ofthe input of a given brain area.In the second part we developed, departing from this viral vector, a newvariant to facilitate the tracing and reconstructing of morphologic features of neurons.We showed the strength of this anterograde variant of the recombinant glycoproteindeletedrabies virus for computational reconstruction of all key morphologicalfeatures of neurons: dendrites, spines, long-ranging axons throughout the brain andbouton terminals.In the third part we examined alterations in the wiring of brain structures inthe Fragile X Syndrome (FXS). FXS is the most common inherited mental retardationand most frequent genetic form of autism, leading to learning and memory deficits,repetitive behavior, seizures and hypersensitivity to sensory (e.g. visual) stimuli. Oneof the eminent hypotheses in the autism field assumes a local hyper- connectivityphenotype but hypo-connectivity for long-ranging connections. To test this hypothesisin a FXS mouse model we used magnetic resonance imaging, to scan the entire brainand measure the anatomical and functional connectivity. This allowed us to identifyconnectivity alterations in several areas that we further explored using viral tracers.Using retrograde rabies virus to count the number of neurons projecting to such areaswe confirmed an altered input connectivity to the primary visual cortex, which couldcontribute to the altered visual information processing. We discovered an overallreduced anatomical and functional long-range connectivity between several brainareas, identifying FXS as pathology of neuronal connectivity, which might explain thedifficulties several rescue strategies aiming at molecular targets are currently facing
Books on the topic "Fragile X syndrome"
1949-, Hagerman Randi Jenssen, and Cronister Amy 1957-, eds. Fragile X syndrome: Diagnosis, treatment, and research. 2nd ed. Baltimore: Johns Hopkins University Press, 1996.
Find full textBen-Yosef, Dalit, and Yoav Mayshar, eds. Fragile-X Syndrome. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9080-1.
Full textJu, Sung Ying, and Denman Robert B, eds. The molecular basis of fragile X syndrome. Kerala, India: Research Signpost, 2005.
Find full textDenman, Robert B., ed. Modeling Fragile X Syndrome. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-21649-7.
Full textE, Davies K., ed. The Fragile X syndrome. Oxford: Oxford University Press, 1989.
Find full textBraden, Marcia L. Fragile: Handle with care : understanding fragile X syndrome. Chapel Hill, N.C: Avanta Pub. Co., 1996.
Find full textNational Institutes of Health (U.S.), ed. Families and fragile X syndrome. [Bethesda, MD]: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 2003.
Find full textSaunders, Suzanne. Fragile X syndrome: A review of literature. Oxford: Westminster College, Centre for the Study of Special Education, 1996.
Find full textNational Institute of Child Health and Human Development (U.S.) and National Institutes of Health (U.S.), eds. Facts about fragile X syndrome. [Washington, D.C.?]: National Institutes of Child Health and Human Development, 1996.
Find full textNational Institute of Child Health and Human Development (U.S.) and National Institutes of Health (U.S.), eds. Facts about fragile X syndrome. [Washington, D.C.?]: National Institutes of Child Health and Human Development, 1996.
Find full textBook chapters on the topic "Fragile X syndrome"
Reches, Adi. "Fragile X Syndrome: Introduction." In Fragile-X Syndrome, 3–10. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9080-1_1.
Full textVertkin, Irena, and Dalit Ben-Yosef. "Imaging of Somatic Ca2+ Transients in Differentiated Human Neurons." In Fragile-X Syndrome, 123–29. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9080-1_10.
Full textTelias, Michael, and Menahem Segal. "Patch-Clamp Recordings from Human Embryonic Stem Cells-Derived Fragile X Neurons." In Fragile-X Syndrome, 131–39. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9080-1_11.
Full textKong, Ha Eun, Junghwa Lim, and Peng Jin. "Application of Drosophila Model Toward Understanding the Molecular Basis of Fragile X Syndrome." In Fragile-X Syndrome, 141–53. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9080-1_12.
Full textTelias, Michael. "Fragile X Syndrome Pre-Clinical Research: Comparing Mouse- and Human-Based Models." In Fragile-X Syndrome, 155–62. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9080-1_13.
Full textElizur, Shai E., Moran Friedman Gohas, Olga Dratviman-Storobinsky, and Yoram Cohen. "Pathophysiology Mechanisms in Fragile-X Primary Ovarian Insufficiency." In Fragile-X Syndrome, 165–71. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9080-1_14.
Full textZafarullah, Marwa, and Flora Tassone. "Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)." In Fragile-X Syndrome, 173–89. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9080-1_15.
Full textCai, Xiaoqiang, Mohammad Arif, Haolei Wan, Ruth Kornreich, and Lisa J. Edelmann. "Clinical Genetic Testing for Fragile X Syndrome by Polymerase Chain Reaction Amplification and Southern Blot Analyses." In Fragile-X Syndrome, 11–27. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9080-1_2.
Full textEpsztejn-Litman, Silvina, and Rachel Eiges. "Monitoring for Epigenetic Modifications at the FMR1 Locus." In Fragile-X Syndrome, 29–48. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9080-1_3.
Full textHayward, Bruce E., and Karen Usdin. "Assays for Determining Repeat Number, Methylation Status, and AGG Interruptions in the Fragile X-Related Disorders." In Fragile-X Syndrome, 49–59. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9080-1_4.
Full textConference papers on the topic "Fragile X syndrome"
Silva, Bruno Custódio, Gisele Delazeri, Ana Luíza Kolling Konopka, Giulia Righetti Tuppini Vargas, Paulo Ricardo Gazzola Zen, and Rafael Fabiano Machado Rosa. "Report of a family affected by fragile X syndrome and type 1 diabetes mellitus." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.076.
Full textBrown, Collis, Sonya Sobrian, and Tamaro Hudson. "Therapeutic Efficacy of Macamides on Fragile X Tremor/Ataxia Syndrome (FXT/AS)." In ASPET 2023 Annual Meeting Abstracts. American Society for Pharmacology and Experimental Therapeutics, 2023. http://dx.doi.org/10.1124/jpet.122.201750.
Full textKwon, Hyunwoo. "Construction of transgenic cell line for production of a canine model of Fragile X Syndrome." In 2021 IEEE 3rd Global Conference on Life Sciences and Technologies (LifeTech). IEEE, 2021. http://dx.doi.org/10.1109/lifetech52111.2021.9391947.
Full textKazanci, Serdar, Elizabeth Berry-Kravis, and Deborah Hall. "Fragile-X-associated Tremor/Ataxia Syndrome in a Woman with Full Mutation: A Case Report (P5-11.009)." In 2023 Annual Meeting Abstracts. Lippincott Williams & Wilkins, 2023. http://dx.doi.org/10.1212/wnl.0000000000203531.
Full textTyagi, Richa, Tanishka S. Saraf, and Clinton E. Canal. "The serotonergic psychedelicN,N-Dipropyltryptamine prevents seizures in a mouse model of fragile X syndrome via an apparent non-serotonergic mechanism." In ASPET 2023 Annual Meeting Abstracts. American Society for Pharmacology and Experimental Therapeutics, 2023. http://dx.doi.org/10.1124/jpet.122.145310.
Full textReports on the topic "Fragile X syndrome"
Larson, John R. Cellular Basis for Learning Impairment in Fragile X Syndrome. Fort Belvoir, VA: Defense Technical Information Center, August 2014. http://dx.doi.org/10.21236/ada613717.
Full textHagerman, Randi. Treatment of Fragile X Syndrome with a Neuroactive Steroid. Fort Belvoir, VA: Defense Technical Information Center, August 2014. http://dx.doi.org/10.21236/ada613986.
Full textHagerman, Randi. Treatment of Fragile X Syndrome with a Neuroactive Steroid. Fort Belvoir, VA: Defense Technical Information Center, August 2012. http://dx.doi.org/10.21236/ada580938.
Full textLarson, John R. Cellular Basis for Learning Impairment in Fragile X Syndrome. Fort Belvoir, VA: Defense Technical Information Center, August 2013. http://dx.doi.org/10.21236/ada586251.
Full textHagerman, Randi. Treatment of Fragile X Syndrome with a Neuroactive Steroid. Fort Belvoir, VA: Defense Technical Information Center, August 2013. http://dx.doi.org/10.21236/ada592346.
Full textPerlmutter, David H. Pharmacological and Nonpharmacological Methods of Treatment for Fragile X Syndrome. Fort Belvoir, VA: Defense Technical Information Center, February 2004. http://dx.doi.org/10.21236/ada426093.
Full textPerlmutter, David H. Pharmacological and Nonpharmacological Methods of Treatment for Fragile X Syndrome. Fort Belvoir, VA: Defense Technical Information Center, February 2005. http://dx.doi.org/10.21236/ada434383.
Full textCline, Hollis T. Developing Xenopus Laevis as a Model to Screen Drugs for Fragile X Syndrome. Fort Belvoir, VA: Defense Technical Information Center, June 2014. http://dx.doi.org/10.21236/ada608963.
Full textCline, Hollis T. Developing Xenopus Laevis as a Model to Screen Drugs for Fragile X Syndrome. Fort Belvoir, VA: Defense Technical Information Center, October 2013. http://dx.doi.org/10.21236/ada598718.
Full textHagerman, Paul J., and Isaac N. Pessah. Targeted Upregulation of FMRP Expression as an Approach to the Treatment of Fragile X Syndrome. Fort Belvoir, VA: Defense Technical Information Center, August 2014. http://dx.doi.org/10.21236/ada608931.
Full text